Morgan Stanley
WINT

Morgan Stanley’s Windtree Therapeutics Inc WINT Stock Holding History

Morgan Stanley’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,999
Closed -$5K – 6785
2017
Q1 		$5K Sell
3,999
-31
-0.8% -$40 ﹤0.01% 6376
2016
Q4 		$5K Sell
4,030
-214
-5% -$395 ﹤0.01% 6289
2016
Q3 		$11K Sell
4,244
-35
-0.8% -$76 ﹤0.01% 6104
2016
Q2 		$8K Sell
4,279
-141
-3% -$341 ﹤0.01% 6128
2016
Q1 		$7K Buy
4,420
+140
+3% +$301 ﹤0.01% 6229
2015
Q4 		$13K Sell
4,280
-6,846
-62% -$28.1K ﹤0.01% 6185
2015
Q3 		$47K Buy
11,126
+3,148
+39% +$20.8K ﹤0.01% 5761
2015
Q2 		$76K Sell
7,978
-15,165
-66% -$213K ﹤0.01% 5723
2015
Q1 		$386K Buy
23,143
+6,338
+38% +$125K ﹤0.01% 4814
2014
Q4 		$273K Buy
16,805
+15,672
+1,383% +$345K ﹤0.01% 5060
2014
Q3 		$29K Sell
1,133
-21
-2% -$507 ﹤0.01% 5898
2014
Q2 		$29K Sell
1,154
-22,870
-95% -$585K ﹤0.01% 5932
2014
Q1 		$723K Buy
24,024
+21,947
+1,057% +$738K ﹤0.01% 4272
2013
Q4 		$65K Buy
2,077
+132
+7% +$4.13K ﹤0.01% 5506
2013
Q3 		$53K Sell
1,945
-4,950
-72% -$120K ﹤0.01% 5188
2013
Q2 		$147K Buy
+6,895
New +$170K ﹤0.01% 4974

Other funds holding WINT

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Morgan Stanley's WINT Position: Q2 2017 in Review

Morgan Stanley sold out of Windtree Therapeutics Inc (WINT) in Q2 2017, closing a stake of 3,999 shares — an estimated $5K sold.

Morgan Stanley first reported a position in WINT in Q2 2013 and held it in 16 quarters. The position peaked at $723K in Q1 2014. 3 funds tracked by Wall St. Rank hold WINT as of Q2 2017.

  • Morgan Stanley reported no remaining Windtree Therapeutics Inc position as of Q2 2017 after selling out during the quarter.
  • Morgan Stanley sold 3,999 Windtree Therapeutics Inc shares in Q2 2017, an estimated $5K.
  • Morgan Stanley first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 16 quarters.
  • Morgan Stanley's Windtree Therapeutics Inc position peaked at $723K in Q1 2014.
  • 3 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2017.

Based on Morgan Stanley's 13F filing for Q2 2017, filed 11 Aug 2017.